Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery

Clinical trial NCT00814593 · WITHDRAWN

Trial details

NCT number

NCT00814593

Sponsor

Lisata Therapeutics, Inc.

Status

WITHDRAWN

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2008-11-01

Primary completion

2011-04-01

Enrollment

0

View on ClinicalTrials.gov